Sunitinib malate

• 产品号: PZ0012
• CAS号: 341031-54-7
• 分子式: C26H33FN4O7
• 分子量: 532.5612232
• 纯 度: ≥98% (HPLC)

产品别名

• 标题: Sunitinib malate
• IUPAC标准名: (2S)-2-hydroxybutanedioic acid; N-[2-(diethylamino)ethyl]-5-[(5-fluoro-2-oxo-2,3-dihydro-1H-indol-3-ylidene)methyl]-2,4-dimethyl-1H-pyrrole-3-carboxamide
• IUPAC传统名: (-)-malic acid; sunitinib
• 别名: N-[2-(Diethylamino)ethyl]-5-[(Z)-(5-fluoro-1,2-dihydro-2-oxo-3H-indol-3-ylidene)methyl]-2,4-dimethyl-1H-pyrrole-3-carboxamide (2S)-2-hydroxybutanedioic acid (1:1) salt; SU 11248; SU 011248; SU112248

产品登记号

• MDL号: MFCD08282795
• CAS号: 341031-54-7

产品性质

• Empirical Formula (Hill Notation): C22H27FN4O2 · C4H6O5
• 纯度: ≥98% (HPLC)
• 外观: powder
• 溶解度: DMSO: >10 mg/mL
• GHS警示词: Danger
• GHS危险声明: H360-H372
• 欧盟危险性物质标志: 有毒(Toxic) (T)
• GHS警示性声明: P201-P308 + P313
• 危险公开号: 61-2-48/25
• 安全公开号: 53-22-36/37
• 保存温度: room temp
• 德国WGK号: 2

产品详细信息

详细说明 (English)

Biochem/physiol Actions
Sunitinib malate is a receptor tyrosine kinase inhibitor, which targets VEGF-R1, VEGF-R2, VEGF-R3, PDGF-Rα, PDGF-Rβ, KIT, FLT3, CSF-1R, and RET. Sunitinib malate is an anticancer drug.
Legal Information
Sold for research purposes under agreement from Pfizer Inc.

详细说明 (简体中文)

Biochem/physiol Actions
Sunitinib malate is a receptor tyrosine kinase inhibitor, which targets VEGF-R1, VEGF-R2, VEGF-R3, PDGF-Rα, PDGF-Rβ, KIT, FLT3, CSF-1R, and RET. Sunitinib malate is an anticancer drug.
Legal Information
Sold for research purposes under agreement from Pfizer Inc.